PRIYANKA SHAH: Open Payments
NPI 1992253686 · VISALIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,849 in 76 payments from 12 companies in 2025. Trend: 2023 $1,670 · 2024 $921 · 2025 $1,849
Food & beverage: $1,849
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 21 | $501 |
| PFIZER INC. | 9 | $215 |
| Galderma Laboratories, L.P. | 2 | $189 |
| ABBVIE INC. | 3 | $185 |
| GENZYME CORPORATION | 5 | $172 |
| Janssen Biotech, Inc. | 12 | $171 |
| UCB, Inc. | 13 | $161 |
| Arcutis Biotherapeutics, Inc. | 5 | $91 |
| Novartis Pharmaceuticals Corporation | 2 | $60 |
| LEO Pharma Inc. | 2 | $53 |
Products named: Opzelura, CIBINQO, DUPIXENT, NEMLUVIO, TREMFYA, Bimzelx, BOTOX, Zoryve.
Industry payments across CA — which companies pay providers there.
